In line with previous studies using high-fat diet-fed, carcinogen-induced56 and engrafted55,57 PDAC models, our results show that metformin effectively prevents the progression of advanced PanINs and the development of KRAS-driven PDAC promoted by diet-induced obesity. The gene discussed is KRAS; the disease is obesity due to melanocortin 4 receptor deficiency.